Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Long-term risk of breast cancer recurrence: The need for extended adjuvant therapy
Manfred Kaufmann
*
,
Achim Rody
*
Corresponding author for this work
Clinic of Gynecology and Obstetrics
Johann Wolfgang Goethe-University
25
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Long-term risk of breast cancer recurrence: The need for extended adjuvant therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Aromatase Inhibitor
28%
Breast Cancer
100%
Disease Free Survival
14%
Estrogen Receptor
28%
Estrogen Synthesis
14%
Letrozole
57%
Neoplasm
28%
Overall Survival
14%
Placebo
14%
Postmenopause
28%
Recurrent Disease
42%
Pharmacology, Toxicology and Pharmaceutical Science
Aromatase Inhibitor
28%
Breast Cancer
100%
Disease Free Survival
14%
Neoplasm
28%
Overall Survival
14%
Placebo
14%
Recurrent Disease
42%